BD9752255
5-(2-Fluoro-3-methoxyphenyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione , 97% , 1150560-59-0
CAS NO.:1150560-59-0
Empirical Formula: C20H15F5N2O3
Molecular Weight: 426.34
MDL number: MFCD30570283
Pack Size | Price | Stock | Quantity |
1g | RMB113.60 | In Stock |
|
5g | RMB402.40 | In Stock |
|
25g | RMB1407.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Density | 1.401±0.06 g/cm3(Predicted) |
storage temp. | Store at room temperature |
pka | 8.61±0.40(Predicted) |
Appearance | White to off-white Solid |
InChI | InChI=1S/C20H15F5N2O3/c1-10-16(11-5-3-8-15(30-2)17(11)22)18(28)26-19(29)27(10)9-12-13(20(23,24)25)6-4-7-14(12)21/h3-8H,9H2,1-2H3,(H,26,28,29) |
InChIKey | RKWZHFVZKOVXSK-UHFFFAOYSA-N |
SMILES | C1(=O)N(CC2=C(C(F)(F)F)C=CC=C2F)C(C)=C(C2=CC=CC(OC)=C2F)C(=O)N1 |
Description and Uses
5-?(2-?Fluoro-?3-?methoxyphenyl)?-?1-?[[2-?fluoro-?6-?(trifluoromethyl)?phenyl]?methyl]?-?6-?methyl-?2,?4(1H,?3H)?-?pyrimidinedione is an intermediate in the synthesis of Elagolix, a gonadotropin-releasing hormone antagonist (GnRH) used in the treatment of endometriosis.
Safety
Symbol(GHS) | ![]() GHS07 |
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P280-P301+P312-P302+P352-P305+P351+P338 |